By Dr. Meg Spriggs and Professor David Nutt  On October 17th 2020, New Zealanders will be given the opportunity to change the way recreational cannabis use is viewed and treated. At present, recreational cannabis use¹ is illegal under the Misuse of Drugs Act 1975 (either class B or C depending on its form). Despite this,  …

Read the full paper here (open access) Drug Science submits it’s finding concerning the UK Medical cannabis industry. In our recent peer-reviewed publication, Drug Science examines the current barriers to prescribing medical cannabis; ethical issues that arise from that process and we present our recommendations for best practice within this space. In the UK, medical  …

The tables have been turned in this one-off special of the Drug Science podcast. In this episode, Professor David Nutt is interviewed by renowned singer-songwriter – Joss Stone. Professor Nutt is the Chair of the Drug Science Scientific Committee and currently the Edmund J Safra Professor of Neuropsychopharmacology and Head of the Neuropsychopharmacology Unit at  …

Lucy Stafford is a medical cannabis patient and advocate. Having spent most of her teenage years in severe pain, dependent on opiates and a feeding tube, discovering medical cannabis has transformed her health and quality of life. She is passionate about working towards a healthcare system that integrates the use of medical cannabis in the  …

Article from Drug Science’s Head of Research – Dr Anne Schlag An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK? Despite the legalization of medical cannabis in the UK in November 2018, patients still lack access to this medicine, with fewer than 10 NHS prescriptions having been written  …